Who are Liberal Red blood cell transfusion's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Red Blood Cell Transfusion, Deep-frozen platelets, Cryopreserved platelets, Liquid-stored platelets.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/liberal-red-blood-cell-transfusion.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Liberal Red blood cell transfusion — Competitive Intelligence Brief

Liberal Red blood cell transfusion (Liberal Red blood cell transfusion) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Blood product / Cellular therapy. Area: Hematology / Critical Care / Perioperative Medicine.

phase 3 Blood product / Cellular therapy Hematology / Critical Care / Perioperative Medicine Biologic Live · refreshed every 30 min

Target snapshot

Liberal Red blood cell transfusion (Liberal Red blood cell transfusion) — Assistance Publique - Hôpitaux de Paris. Liberal red blood cell transfusion increases circulating hemoglobin and oxygen-carrying capacity by administering donor red blood cells to patients with anemia or blood loss.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Liberal Red blood cell transfusion TARGET	Liberal Red blood cell transfusion	Assistance Publique - Hôpitaux de Paris	phase 3	Blood product / Cellular therapy
Red Blood Cell Transfusion	Red Blood Cell Transfusion	Rutgers, The State University of New Jersey	marketed	Blood product / Cellular therapy
Deep-frozen platelets	Deep-frozen platelets	Alrijne Ziekenhuis Leiderdorp	phase 3	Blood product / Cellular therapy
Cryopreserved platelets	Cryopreserved platelets	Australian and New Zealand Intensive Care Research Centre	phase 3	Blood product / Cellular therapy
Liquid-stored platelets	Liquid-stored platelets	Australian and New Zealand Intensive Care Research Centre	phase 3	Blood product / Cellular therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Blood product / Cellular therapy class)

Australian and New Zealand Intensive Care Research Centre · 2 drugs in this class
Alrijne Ziekenhuis Leiderdorp · 1 drug in this class
Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Rutgers, The State University of New Jersey · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Liberal Red blood cell transfusion — Competitive Intelligence Brief. https://druglandscape.com/ci/liberal-red-blood-cell-transfusion. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab